Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,581 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Los Angeles CA, Newport Beach CA, Houston TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase 1, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Los Angeles CA, Duarte CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase 1, Phase 2, Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Los Angeles CA, South Pasadena CA, Pasadena CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04510597

Phase 3, Recruiting

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

for
Breast Carcinoma
Location: Los Angeles CA, Newport Beach CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT06336928

Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Los Angeles CA, South Pasadena CA, Burbank CA,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for
Metastatic Nasopharyngeal Carcinoma,
Location: Los Angeles CA, Newport Beach CA, Fresno CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Los Angeles CA, Beverly Hills CA, Burbank CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase 2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Los Angeles CA, Newport Beach CA, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

for
Cerebral Palsy, Hip Dysplasia, Pain, Postoperative
Location: Los Angeles CA, Santa Monica CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 0 - 18

Code: NCT06189781

Recruiting

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

for
Von Willebrand Diseases
Location: Los Angeles CA, Sacramento CA, Aurora CO, Seattle WA,
Sponsor: Vega Therapeutics, Inc

Sex: All

Age: 12 - 60

Code: NCT05776069

Phase 1, Phase 2, Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

for
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Location: Los Angeles CA, Sacramento CA, Oklahoma City OK,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 12 - 70+

Code: NCT04647227

Recruiting

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

for
Von Willebrand Disease (VWD)
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Vega Therapeutics, Inc

Sex: All

Age: 12 - 70+

Code: NCT07115004

Phase 3, Recruiting

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

for
Hemophilia A
Location: Los Angeles CA, Torrance CA, Boise ID, Portland OR,
Sponsor: Green Cross Corporation

Sex: All

Age: 12+

Code: NCT01619046

Phase 3, Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

for
Hemophilia B
Location: Los Angeles CA, San Francisco CA, Sacramento CA,
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 2+

Code: NCT06379789

Phase 1, Phase 2, Recruiting

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

for
Severe Hemophilia A
Location: Los Angeles CA, Greenville NC
Sponsor: Pfizer

Sex: Male

Age: 12 - 70+

Code: NCT06703606

Phase 1, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Los Angeles CA, San Bernardino CA, San Diego CA,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting
New

A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

for
Nasal Polyps
Location: Los Angeles CA, Tulsa OK
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07782970

Phase 3, Recruiting

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

for
Solid Tumors, Sarcomas
Location: Los Angeles CA, St Louis MO, Sarasota FL, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07374848

Phase 1, Recruiting

Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers

for
Peripheral Artery Disease,
Location: Los Angeles CA, Downey CA, Carlsbad CA,
Sponsor: AnGes USA, Inc.

Sex: All

Age: 18+

Code: NCT04267640

Phase 2, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Los Angeles CA, West Hills CA, Oxnard CA, Avondale AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles